This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Measure of benefits used in the economic analysis
The measures of benefit used were the quality-adjusted life-years (QALY) gained and the number of DFDs gained during the year following the intervention. DFDs were transformed into QALYs using weights from "the literature" and 6 sources were referred to. The transition from fully symptomatic depression to full remission was taken to be 0.4 QALYs.
Direct costs
Discounting was not carried out as costs were incurred during less than 1 year. The quantities of medical service use per patient were given, but the quantities and the costs were not reported separately. The costs measured for the intervention were for teen group intervention sessions, parent group information sessions, group leader training, electronic identification of the patient population, chart review for parent depression status, HMO provider time and outreach and recruitment of parents and teens. The costs of the intervention were estimated using actual data obtained from the clinical trial records and study staff estimates. The costs of usual care were obtained from electronic HMO data, while participants were also given surveys to register any non-HMO resource use. The unit costs were obtained from other studies referred to in the study and local market unit costs. Family transportation costs were estimated from patient utilisation data and other information. The price year was 2000.
